Boston Scientific Corporation (LON:0HOY)

London flag London · Delayed Price · Currency is GBP · Price in USD
97.39
+0.94 (0.97%)
At close: Oct 9, 2025
0.97%
Market Cap108.38B
Revenue (ttm)13.50B
Net Income (ttm)1.83B
Shares Outn/a
EPS (ttm)1.23
PE Ratio59.28
Forward PE30.94
Dividendn/a
Ex-Dividend Daten/a
Volume4,948
Average Volume21,141
Open96.76
Previous Close96.45
Day's Range96.69 - 97.65
52-Week Range80.50 - 109.51
Beta0.61
RSI42.12
Earnings DateOct 22, 2025

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1979
Employees 53,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HOY
Full Company Profile

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD Financial Statements

News

November 28th Options Now Available For Boston Scientific (BSX)

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the November 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BS...

1 day ago - Nasdaq

4 Top AI-Powered Healthcare Stocks

Healthcare stocks quietly outperformed the market in the past 30 days as headlines centered on the government shutdown over the extension of Affordable Care Act tax credits for 2026. The AI in healthc...

1 day ago - Seeking Alpha

Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings

Read here for Boston Scientific (BSX) stock's outlook ahead of Q3 earnings, assess valuation, margin pressures, and acquisition impacts.

1 day ago - Seeking Alpha

Evercore ISI Revises Boston Scientific (BSX) Price Target to $110 | BSX Stock News

Evercore ISI Revises Boston Scientific (BSX) Price Target to $110 | BSX Stock News

3 days ago - GuruFocus

Boston Scientific (BSX) Target Price Cut by Evercore ISI Amid Market Concerns

Boston Scientific (BSX) Target Price Cut by Evercore ISI Amid Market Concerns

3 days ago - GuruFocus

The Zacks Analyst Blog Highlights Boston Scientific, Union Pacific, Realty Income and Weyco

BSX, UNP, O, and WEYS stand out with strong sector performance, resilient cash flows, and strategic growth moves, despite headwinds from tariffs, e-commerce, and macro uncertainties.

7 days ago - Nasdaq

Top Research Reports for Boston Scientific, Union Pacific & Realty Income

Boston Scientific gains from MedSurg and cardiovascular strength, while Union Pacific and Realty Income face mixed headwinds.

7 days ago - Nasdaq

BSX Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our P/E/Growth Investor model based on the published strategy ...

9 days ago - Nasdaq

Boston Scientific (BSX) Analyst Rating Update: Canaccord Genuity Raises Price Target | BSX ...

Boston Scientific (BSX) Analyst Rating Update: Canaccord Genuity Raises Price Target | BSX Stock News

9 days ago - GuruFocus

Boston Scientific (BSX) Acquires BioEnvelope Business for $88M

Boston Scientific (BSX) Acquires BioEnvelope Business for $88M

9 days ago - GuruFocus

Baird Raises Price Target for Boston Scientific (BSX) to $128.00 | BSX Stock News

Baird Raises Price Target for Boston Scientific (BSX) to $128.00 | BSX Stock News

9 days ago - GuruFocus

Boston Scientific (BSX): Analyst Mike Matson Reiterates Buy Rating | BSX Stock News

Boston Scientific (BSX): Analyst Mike Matson Reiterates Buy Rating | BSX Stock News

9 days ago - GuruFocus

Boston Scientific Corporation (BSX) 2025 Investor Day Call (Transcript)

Discover Boston Scientific's latest investor insights, 3-year growth strategies

9 days ago - Seeking Alpha

Boston Scientific Corporation (BSX) Analyst/Investor Day Transcript

Boston Scientific Corporation (NYSE:BSX) Analyst/Investor Day September 30, 2025 8:30 AM EDT Company Participants Lauren Tengler - Director of Investor Relations Michael Mahoney - Chairman, President...

9 days ago - Seeking Alpha

If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today

Boston Scientific (NYSE: BSX) has outperformed the market over the past 15 years by 7.91% on an annualized basis producing an average annual return of 20.24%. Currently, Boston Scientific has a marke...

15 days ago - Benzinga

Top 3 Health Care Stocks That May Explode In September

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go ...

21 days ago - Benzinga

Top 3 Health Care Stocks That May Explode In September

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

21 days ago - Benzinga

Noteworthy Tuesday Option Activity: BSX, FDX, PYPL

Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Boston Scientific Corp. (Symbol: BSX), where a total of 39,928 contracts have traded so far, rep...

24 days ago - Nasdaq

Relative Strength Alert For Boston Scientific

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a tec...

24 days ago - Nasdaq

Boston Scientific Breaks Below 200-Day Moving Average - Notable for BSX

In trading on Monday, shares of Boston Scientific Corp. (Symbol: BSX) crossed below their 200 day moving average of $100.54, changing hands as low as $100.39 per share. Boston Scientific Corp. shares ...

24 days ago - Nasdaq

Peter Lynch Detailed Fundamental Analysis - BSX

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our P/E/Growth Investor model based on the published strategy ...

25 days ago - Nasdaq

Pre-tax profits at Irish arm of Boston Scientific increase by 52pc to $111m

Pre-tax profits at the main Irish arm of medical device manufacturer Boston Scientific last year increased by 52pc to $111.15m (94.8m).

4 weeks ago - Independent Ireland

Elutia (ELUT) Sells Bioenvelopes to Boston Scientific

Elutia (ELUT) Sells Bioenvelopes to Boston Scientific

4 weeks ago - GuruFocus

Boston Scientific (BSX) Purchases Elutia's Bioenvelope Assets in $88 Million Deal

Boston Scientific (BSX) Purchases Elutia's Bioenvelope Assets in $88 Million Deal

4 weeks ago - GuruFocus